Strides Potassium Chloride Tablets Recall: Oversized Tablets Risk
Strides Pharma recalls Potassium Chloride Extended-Release Tablets with oversized tablets in specific lots. These tablets may cause injury if taken. Check your NDC and lot numbers for affected products.
Lower-risk recall
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Contact the company
What happened, in plain English
Strides Pharma is recalling Potassium Chloride Extended-Release Tablets that contain oversized tablets in certain lots. This could lead to injury if taken as directed. Read more at govinfonow.com/recall/37372-strides-potassium-chloride-tablets-recall-oversized-tablets-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37372-strides-potassium-chloride-tablets-recall-oversized-tablets-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1029-2020
Cite this page
“Strides Potassium Chloride Tablets Recall: Oversized Tablets Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37372-strides-potassium-chloride-tablets-recall-oversized-tablets-risk. Based on FDA recall #D-1029-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1029-2020%22&limit=1).
Why it’s dangerous
Oversized tablets may not dissolve properly in the stomach, potentially causing injury if taken as directed. This is a manufacturing issue that occurred in specific production lots.
Who’s affected
Prescription patients who own the recalled Potassium Chloride Extended-Release Tablets with specific NDC and lot numbers. Those at highest risk are patients taking potassium supplements for medical conditions.
How to tell if you have this one
Check for NDC 64380-861-08 and lot numbers 7238958A, 7238257A (expiring 7/31/2021) or 7239404A (expiring 9/30/2021). The product is a prescription-only 1000-count bottle of Potassium Chloride Extended-Release Tablets.
- Brand
Strides- Category
Drug
What to do — step by step
Check Product Details
Verify your NDC number and lot number against the recalled items listed in the notice.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
The recall does not require immediate action; check your product details and contact your doctor or pharmacist if you have concerns.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1029-2020 (February 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1029-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.